A Novel Composite Endpoint of Toxicity- and Progression-Free Survival after B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma

被引：0

作者：

Mohty, Razan ^{[1
]}

Junmin, Whiting ^{[2
]}

Saha, Aditi ^{[3
]}

Kim, Jongphil ^{[2
]}

Nishihori, Taiga ^{[1
]}

De Avila, Gabriel ^{[4
]}

Corallo, Salvatore ^{[1
]}

Dam, Marian ^{[1
]}

Marin, Jessica ^{[1
]}

Liu, Hien ^{[5
]}

Mokhtari, Sepideh ^{[6
]}

Jain, Michael D. ^{[1
]}

Perna, Fabiana ^{[7
]}

Blue, Brandon ^{[3
]}

Grajales-Cruz, Ariel F. ^{[4
]}

Castaneda, Omar ^{[8
]}

Shain, Kenneth ^{[4
]}

Baz, Rachid ^{[3
]}

Freeman, Ciara Louise L. ^{[8
]}

Alsina, Melissa ^{[5
]}

Locke, Frederick L. ^{[1
,5
]}

Hansen, Doris K.

Lazaryan, Aleksandr ^{[1
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA

[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA

[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[5] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL USA

[7] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Indianapolis, IN USA

[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA

来源：

关键词：

D O I：

10.1182/blood-2023-184406

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5